Seattle Children’s Hospital

Date of Award

11.06.2019

Program

Prevent & Delay

Amount

$4,188,786.00

Term of Grant

43 months

Project Title

Development of antigen-specific eTreg therapy in T1D - Stage 3 Studies

Project Description

Funds will support studies to develop an engineered targeted Treg cell therapy to treat type 1 diabetes.